Eli Lilly Sues 4 GLP-1 Telehealth Startups, Escalating War on Knockoff Drugs
Pharmaceutical giant Eli Lilly alleges the companies are selling off-brand versions of its best-selling diabetes and weight-loss drugs, Mounjaro and Zepbound.

Apr 23, 2025 0
Apr 23, 2025 0
Apr 22, 2025 0
Apr 22, 2025 0
Apr 19, 2025 0
Or register with email
Apr 18, 2025 0
Apr 18, 2025 0
Apr 18, 2025 0
Apr 4, 2025 0
Apr 18, 2025 0
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.